HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In situ subungual melanoma: digit salvaging clearance.

Abstract
Acral lentiginous melanoma affecting the nail is uncommon but carries a poor prognosis due to difficulties in early diagnosis. The gold standard of treatment for subungual melanoma is biopsy followed by wide local excision in form of amputation of the distal phalanx of the digit, in order to achieve at least 10 mm margin of clearance or by fixed tissue micrographic (Mohs') surgery. Here, we demonstrate a non-amputative approach for the excision of subungual melanoma in situ of the right great toe, involving removal of the nail unit with a layer of underlying bone before reconstruction with full thickness skin graft. This technique allows adequate excision margins to ensure full clearance of the lesion with satisfactory preservation of function.
AuthorsW T H Chow, W Bhat, S Magdub, A Orlando
JournalJournal of plastic, reconstructive & aesthetic surgery : JPRAS (J Plast Reconstr Aesthet Surg) Vol. 66 Issue 2 Pg. 274-6 (Feb 2013) ISSN: 1878-0539 [Electronic] Netherlands
PMID22809529 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2012 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
Topics
  • Adult
  • Biopsy, Needle
  • Carcinoma in Situ (pathology, surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Immunohistochemistry
  • Melanoma (pathology, surgery)
  • Nail Diseases (pathology, surgery)
  • Nails (surgery)
  • Plastic Surgery Procedures (methods)
  • Risk Assessment
  • Salvage Therapy (methods)
  • Skin Neoplasms (pathology, surgery)
  • Skin Transplantation (methods)
  • Toes
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: